Company: BL
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001628280-25-050628
Chunk: 14

Company: BLACKLINE, INC.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 14
---
-for-sale securities are available for use in current operations and are categorized as current assets. Refer to “Note 7 - Fair Value Measurements” for additional information. The Company recognized accretion on its marketable securities of $3.1 million and $8.5 million in interest income for the quarter and nine months ended September 30, 2025, respectively. The Company recognized accretion on its marketable securities in interest income, and also recognized net gains and losses related to maturities of marketable securities that were reclassified from accumulated other comprehensive loss in interest income of $2.9 million and $18.1 million for the quarter and nine months ended September 30, 2024, respectively.Net gains and losses are determined using the specific identification method. During the quarter and nine months ended September 30, 2025, the Company had no sales of marketable securities, and therefore, no related realized gains or losses were recognized in the unaudited condensed consolidated statements of operations. During the quarter and nine months ended September 30, 2024, there were nominal realized gains and losses related to sales of marketable securities recognized in the Company's unaudited condensed consolidated statements of operations. There were no marketable securities in a continuous loss position for greater than or less than 12 months at September 30, 2025.The Company's marketable securities are considered to be of high credit quality and accordingly, there was no allowance for credit losses related to marketable securities at September 30, 2025.Other AssetsDeferred customer contract acquisition costs are included in other assets in the unaudited condensed consolidated balance sheets and totaled $86.6 million and $86.1 million at September 30, 2025 and December 31, 2024, respectively.Accrued Expenses and Other Current LiabilitiesAccrued expenses and other current liabilities were comprised of the following (in thousands):September 30,2025December 31,2024Accrued salaries and employee benefits$35,431 $41,833 Accrued income and other taxes payable14,024 11,297 Accrued restructuring costs2,049 — Other accrued expenses and current liabilities24,117 18,444 $75,621 $71,574 Derivative InstrumentsThe Company uses foreign currency forward contracts with an approximate maturity of one month to mitigate foreign currency exchange rate fluctuations on certain foreign currency-denominated monetary assets. Under ASC